Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Peloton Therapeutics Inc.
DescriptionSmall molecule inhibitor of endothelial PAS domain protein 1 (HIF2A; HIF-2alpha; EPAS1)
Molecular Target Endothelial PAS domain protein 1 (HIF2A) (HIF-2alpha) (EPAS1)
Mechanism of ActionHypoxia-inducible factor 2 alpha (HIF2A) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today